Similar articles

• Allogeneic versus autologous bone marrow transplantation versus intensive post-remission chemotherapy in acute leukaemias.

  Bernasconi C, Lazzarino M, Canevari A, Morra E, Castelli G, Brusamolino E, Alessandrino EP, Pagnucco G, Orlandi E, Castagnola C, et al. Bernasconi C, et al. Bone Marrow Transplant. 1989 Dec;4 Suppl 4:65-8. Bone Marrow Transplant. 1989. PMID: 2697439 Review. No abstract available.
• High dose therapy and autologous bone marrow transplant (ABMT) in acute leukemia: is purging necessary?

  Dicke KA, Spinolo JA. Dicke KA, et al. Bone Marrow Transplant. 1989 Jan;4 Suppl 1:184-6. Bone Marrow Transplant. 1989. PMID: 2653500 Review.
• "Quality" remissions: a new target of induction therapy in acute leukemia and the next step in developing curative treatment.

  Arlin ZA, Feldman EJ, Finger L, Ahmed T, Mittelman A, Puccio C, Cook P, Chun HG. Arlin ZA, et al. Semin Hematol. 1991 Jul;28(3 Suppl 4):44-7. Semin Hematol. 1991. PMID: 1780752 Review. No abstract available.
• Autologous bone marrow transplantation for patients with acute myeloid leukaemia and acute lymphoblastic leukaemia--a comparison.

  Anderson CC, Goldstone AH, Linch DC, Jones HM, Franklin IM, Boughton BJ, Cawley JC, Richards JD. Anderson CC, et al. Bone Marrow Transplant. 1987 Feb;1(3):271-9. Bone Marrow Transplant. 1987. PMID: 3332138
• Autologous bone marrow transplantation (ABMT) using unpurged marrow as intensification for first complete remission in acute leukaemia (AL).

  Kubel M, Helbig W, Schwenke H, Wötzel M, Thierbach V, Standke E, Hoffmann FA. Kubel M, et al. Folia Haematol Int Mag Klin Morphol Blutforsch. 1989;116(3-4):493-8. Folia Haematol Int Mag Klin Morphol Blutforsch. 1989. PMID: 2480296